At the Ohio State Racing Commission’s regularly scheduled meeting on September 17 at the Log Cabin on the grounds of the Delaware County Fairgrounds, the commission voted unanimously to approve an anabolic steroid policy and forward it to the Analytical Toxicology Laboratory at the Ohio Department of Agriculture.
Commissioner Ted Brown made the motion to adopt the new policy and it passed unanimously.
The adoption of this policy ensures that the Commission will be in compliance with the ARCI anabolic steroid model rule on Jan. 1, 2009.
The Ohio State Racing Commissions asks to be notified beginning January 1, 2009, of any of the following: * Any urine that tests positive for 16b-hydroxystanozolol (a metabolite of stanozolol) at a concentration over 1 ng/ml of urine for all horses regardless of sex; * Any urine that tests positive for boldenone at a concentration over 15 ng/ml of urine in male horses other than geldings;
* Any urine that tests positive for boldenone in geldings or female horses;
* Any urine that tests positive for nandrolone at a concentration over 1 ng/ml of urine in geldings, fillies, and mares;
* Any urine that tests positive for 5a-Estrane-3b, 17a-diol (a metabolite of nandrolone) at a concentration over 45 ng/ml of urine in male horses other than geldings; and
* Any urine that tests positive for testosterone at a concentration over 20 ng/ml of urine in geldings; and over 55 ng/ml of urine in fillies and mares.
The Laboratory is not to report any urine sample that tests positive for testosterone if it is from a male horse other than a gelding.
In addition, the Laboratory shall report to the Commission any urine sample which finds (shows) the presence of more than one of the four androgenic anabolic steroids mentioned above at concentrations greater than the individual thresholds indicated above. (Ohio State Racing Commission)
|




